We gratefully acknowledge support from
the Simons Foundation and member institutions.


New submissions

[ total of 3 entries: 1-3 ]
[ showing up to 2000 entries per page: fewer | more ]

New submissions for Wed, 12 May 21

[1]  arXiv:2105.05125 [pdf]
Title: ResAtom System: Protein and Ligand Affinity Prediction Model Based on Deep Learning
Comments: 28 pages, 7 figures, 2 tables
Subjects: Biomolecules (q-bio.BM); Machine Learning (cs.LG)

Motivation: Protein-ligand affinity prediction is an important part of structure-based drug design. It includes molecular docking and affinity prediction. Although molecular dynamics can predict affinity with high accuracy at present, it is not suitable for large-scale virtual screening. The existing affinity prediction and evaluation functions based on deep learning mostly rely on experimentally-determined conformations. Results: We build a predictive model of protein-ligand affinity through the ResNet neural network with added attention mechanism. The resulting ResAtom-Score model achieves Pearson's correlation coefficient R = 0.833 on the CASF-2016 benchmark test set. At the same time, we evaluated the performance of a variety of existing scoring functions in combination with ResAtom-Score in the absence of experimentally-determined conformations. The results show that the use of {\Delta}VinaRF20 in combination with ResAtom-Score can achieve affinity prediction close to scoring functions in the presence of experimentally-determined conformations. These results suggest that ResAtom system may be used for in silico screening of small molecule ligands with target proteins in the future. Availability: https://github.com/wyji001/ResAtom

[2]  arXiv:2105.05220 [pdf]
Title: Retro Drug Design: From Target Properties to Molecular Structures
Comments: 27 pages, 6 figures
Subjects: Biomolecules (q-bio.BM)

To generate drug molecules of desired properties with computational methods is the holy grail in pharmaceutical research. Here we describe an AI strategy, retro drug design, or RDD, to generate novel small molecule drugs from scratch to meet predefined requirements, including but not limited to biological activity against a drug target, and optimal range of physicochemical and ADMET properties. Traditional predictive models were first trained over experimental data for the target properties, using an atom typing based molecular descriptor system, ATP. Monte Carlo sampling algorithm was then utilized to find the solutions in the ATP space defined by the target properties, and the deep learning model of Seq2Seq was employed to decode molecular structures from the solutions. To test feasibility of the algorithm, we challenged RDD to generate novel drugs that can activate {\mu} opioid receptor (MOR) and penetrate blood brain barrier (BBB). Starting from vectors of random numbers, RDD generated 180,000 chemical structures, of which 78% were chemically valid. About 42,000 (31%) of the valid structures fell into the property space defined by MOR activity and BBB permeability. Out of the 42,000 structures, only 267 chemicals were commercially available, indicating a high extent of novelty of the AI-generated compounds. We purchased and assayed 96 compounds, and 25 of which were found to be MOR agonists. These compounds also have excellent BBB scores. The results presented in this paper illustrate that RDD has potential to revolutionize the current drug discovery process and create novel structures with multiple desired properties, including biological functions and ADMET properties. Availability of an AI-enabled fast track in drug discovery is essential to cope with emergent public health threat, such as pandemic of COVID-19.

[3]  arXiv:2105.05221 [pdf, other]
Title: SHREC 2021 track: Retrieval and classification of protein surfaces equipped with physical and chemical properties
Subjects: Biomolecules (q-bio.BM)

This paper presents the methods that have participated in the SHREC 2021 contest on retrieval and classification of protein surfaces on the basis of their geometry and physicochemical properties. The goal of the contest is to assess the capability of different computational approaches to identify different conformations of the same protein, or the presence of common sub-parts, starting from a set of molecular surfaces. We addressed two problems: defining the similarity solely based on the surface geometry or with the inclusion of physicochemical information, such as electrostatic potential, amino acid hydrophobicity, and the presence of hydrogen bond donors and acceptors. Retrieval and classification performances, with respect to the single protein or the existence of common sub-sequences, are analysed according to a number of information retrieval indicators.

[ total of 3 entries: 1-3 ]
[ showing up to 2000 entries per page: fewer | more ]

Disable MathJax (What is MathJax?)

Links to: arXiv, form interface, find, q-bio, recent, 2105, contact, help  (Access key information)